Hypolipidemic and Antioxidant Potentials of Xylopia aethiopica Seed Extract in Hypercholesterolemic Rats

다국어 초록 (Multilingual Abstract)

A short-term study was carried out on Wistar strain rats to determine the effects of Xylopia aethiopica extract on serum and postmitochondrial fractions (PMFs) of visceral organs in experimental hypercholesterolemia. Animals received normal diet and were administered cholesterol orally by intubations at a dose of 40mg/kg/0.3mL, plant extracts at 250mg/kg, and cholestyramine (Questran®, Bristol-Myers Squibb, Hounslow, United Kingdom) at 0.26g/kg five times a week for 8 consecutive weeks. Thereafter the hypolipidemic effects were assessed by measuring total cholesterol, low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol, and triglycerides, whereas the extent of oxidative stress was assayed by measuring thiobarbituric acid–reactive substances and enzymatic antioxidants such as superoxide dismutase, catalase, and reduced glutathione (GSH) in serum and PMF of liver and kidney. We assayed two liver biomarkers—alanine aminotransferase and aspartate aminotransferase—for safety of X. aethiopica at the dose given in this experiment. Cholesterol feeding resulted in a significant increase (P<.05) in body weight of the hypercholesterolemic animals relative to control animals, and administration of X. aethiopica (250mg/kg) caused a more than 60% reduction in body weight. Simultaneous treatment with X. aethiopica and Questran elicited 33.75% and 23.94% reductions, respectively, in serum cholesterol levels of hypercholesterolemic rats. In addition, the LDL-C level decreased significantly (P<.05) by 49.09% and 78.92% in serum and by 64.97% and 37.29% in the liver with cotreatment with the plant extract and Questran, respectively, compared to untreated hypercholesterolemic rats. X. aethiopica counteracted the decreases in enzymatic antioxidants, especially in GSH, where there was a greater than 300% increase compared with hypercholesterolemic animals. This study has shown that intake of X. aethiopica reduced the composition of lipids and produced a favorable lipid profile in the serum and PMF of visceral organs in experimental hypercholesterolemia.

참고문헌 (Reference)

1 Hu FB, "Types of dietary fat and the risk of coronary heart disease: a critical review" 20 : 5-19, 2001

2 Misra HP, "The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase" 24 : 3170-3175, 1972

3 Ross R, "The pathogenesis of atherosclerosis: a perspective for the 1990s" 362 : 801-809, 1993

4 Grundy SM, "The effects of unsaturated dietary fats on absorption, excretion, synthesis and distribution of cholesterol in man" 49 : 1136-1152, 1970

5 Farmer JA, "Statins and myotoxicity" 5 : 96-100, 2003

6 Verschuren WMM, "Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries Study" 274 : 131-136, 1995

7 Lowry OH, "Protein measurement with the Folin phenol reagent" 193 : 265-275, 1951

8 Li N, "Prevalence of coronary heart disease indicated by electrocardiogram abnormalities and risk factors in developing countries" 47 : 599-611, 1994

9 Adaramoye OA, "Possible anti-atherogenic effects of Kolaviron (a Garcina kola seed extract) in hypercholesterolaemic rats" 32 : 40-46, 2005

10 O’Keefe JH, "Optimal low-density lipoprotein is 50 to 70 mg=dL: lower is better and physiologically normal" 43 : 2142-2146, 2004

11 Farombi EO, "Mechanisms for the hepatoprotective action of kolaviron: studies on hepatic enzymes, microsomal lipids and lipid peroxidation in carbon tetrachloride-treated rats" 42 : 75-80, 2000

12 Ahmad-Raus RR, "Lowering of lipid composition in aorta of guinea pigs by Curcuma domestica" 1 : 6-, 2001

13 Schaefer EJ, "Lipoproteins, nutrition, aging, and atherosclerosis" 61 (61): S726-S740, 1995

14 Clarkson TB, "Interactions among dietary fat, protein and cholesterol in arteriosclerosis susceptible pigeon" 11 : 400-404, 1962

15 Willet WC, "Intake of trans fatty acid and the risk of coronary heart disease among women" 431 : 581-585, 1993

16 Tairu AO, "Identification of the key aroma compounds in dried fruits of Xylopia aethiopica" 47 : 3285-3287, 1999

17 Babu PS, "Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats" 166 : 169-175, 1997

18 Nityanand S, "Hypocholesterolemic effect of Commiphora mukul resin (guggul)" 9 : 376-377, 1971

19 Halliwell B, "Free radicals, antioxidants and human disease. Where are we now" 119 : 598-620, 1992

20 Prasad K, "Experimental atherosclerosis and oxygen free radicals" 40 : 835-843, 1989

21 Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultra-centrifuge" 18 : 499-502, 1972

22 Bonanome A, "Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low-density lipoproteins to oxidative modification" 12 : 529-533, 1992

23 Fungwe TV, "Dietary cholesterol stimulated hepatic biosynthesis of triglyceride and reduces oxidation of fatty acids in the rat" 34 : 933-941, 1993

24 Karioti A, "Composition and antioxidant activity of the essential oils of Xylopia aethiopica (Dun) A. Rich. (Annonaceae) leaves, stem bark, root bark and fresh and dried fruits, growing in Ghana" 52 : 8094-8098, 2004

25 Tavazzi L, "Clinical epidemiology of acute myocardial infarction" 138 : S48-S54, 2004

26 Barminas JT, "Chemical composition of seeds and oil of Xylopia aethiopica grown in Nigeria" 53 : 193-198, 1999

27 Claiborne A, "Catalase activity. In: Handbook of Methods for Oxygen Radical Research" CRC Press 234-242, 1989

28 Somova LI, "Cardiovascular and diuretic activity of kaurene derivatives of Xylopia aethiopica and Alepidea amatymbica" 77 : 165-174, 2001

29 Jollow DJ, "Bromobenzene induced liver necrosis: protective role of glutathione and evidence of 3,4-bromobenzene oxide as the hepatotoxic metabolite" 11 : 151-169, 1974

30 Mallika V, "Atherosclerosis pathophysiology and the role of novel risk factors, a clinical biochemistry perspective" 58 : 513-522, 2007

31 Benzi G, "Are reactive oxygen species involved in Alzheimer’s disease" 16 : 661-674, 1995

32 Namiki M, "Antioxidants=antimutages in food" 29 : 273-300, 1990

33 Boakye-Yiadom K, "Antimicrobial properties of some West Africa medical plants IV. Antimicrobial activity of xylopic acid and other constituents of the fruits of Xylopia aethiopica (Annonanceae)" 40 : 543-545, 1977